Concepedia

Marshall A. Diven

MA

Statistics

Publications

4

Citations

81

H-Index

4

Active since

2016

Affiliations

Weill Cornell Medicine(Current)

Cornell University

NewYork–Presbyterian Brooklyn Methodist Hospital

Presbyterian Hospital

Marshall A. Diven is an author at Weill Cornell Medicine specializing in oncology, prostate cancer, and medicine.

Publications per year

2016–2024

4

Publications

4

Toll-like receptor agonist therapy can profoundly augment the antitumor activity of adoptively transferred CD8+ T cells without host preconditioning

Michelle H. Nelson, Jacob S. Bowers, Stefanie R. Bailey et al. · Journal for ImmunoTherapy of Cancer · 2016 · 28 citations · Full text

, , +17

A randomized phase II trial of MR-guided prostate stereotactic body radiotherapy administered in 5 or 2 fractions for localized prostate cancer (FORT)

Sydney Wolfe, Marshall A. Diven, Ariel E. Marciscano et al. · BMC Cancer · 2023 · 20 citations · Full text

, , +17

Trends in Active Surveillance for Men With Intermediate-Risk Prostate Cancer

Marshall A. Diven, Lhaden Tshering, Xiaoyue Ma et al. · JAMA Network Open · 2024 · 19 citations · Full text

, , +17

Differential Use of Radiotherapy Fractionation Regimens in Prostate Cancer

Sarah Qureshy, Marshall A. Diven, Xiaoyue Ma et al. · JAMA Network Open · 2023 · 14 citations · Full text

, , +17

1–4 of 4